AU2007218671B2 - Immunomodulatory and anti-tumour peptides - Google Patents

Immunomodulatory and anti-tumour peptides Download PDF

Info

Publication number
AU2007218671B2
AU2007218671B2 AU2007218671A AU2007218671A AU2007218671B2 AU 2007218671 B2 AU2007218671 B2 AU 2007218671B2 AU 2007218671 A AU2007218671 A AU 2007218671A AU 2007218671 A AU2007218671 A AU 2007218671A AU 2007218671 B2 AU2007218671 B2 AU 2007218671B2
Authority
AU
Australia
Prior art keywords
peptides
peptide
seq
lps
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2007218671A
Other languages
English (en)
Other versions
AU2007218671A1 (en
Inventor
Boris Ernesto Acevedo Castro
Hilda Elisa Garay Perez
Maribel Guerra Vallespi
Gerardo Enrique Guillen Nieto
Osvaldo Reyes Acosta
Isis Del Carmen Torrens Madrazo
Raimundo Ubieta Gomez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centro de Ingenieria Genetica y Biotecnologia CIGB
Original Assignee
Centro de Ingenieria Genetica y Biotecnologia CIGB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centro de Ingenieria Genetica y Biotecnologia CIGB filed Critical Centro de Ingenieria Genetica y Biotecnologia CIGB
Publication of AU2007218671A1 publication Critical patent/AU2007218671A1/en
Application granted granted Critical
Publication of AU2007218671B2 publication Critical patent/AU2007218671B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43509—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from crustaceans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Insects & Arthropods (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2007218671A 2006-02-24 2007-02-23 Immunomodulatory and anti-tumour peptides Ceased AU2007218671B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CU2006-0047 2006-02-24
CU20060047A CU23582A1 (es) 2006-02-24 2006-02-24 Péptidos con capacidad anti-tumoral e inmunomoduladora
PCT/CU2007/000006 WO2007095867A1 (es) 2006-02-24 2007-02-23 Peptidos con capacidad anti-tumoral e inmunomoduladora

Publications (2)

Publication Number Publication Date
AU2007218671A1 AU2007218671A1 (en) 2007-08-30
AU2007218671B2 true AU2007218671B2 (en) 2012-02-09

Family

ID=38123823

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007218671A Ceased AU2007218671B2 (en) 2006-02-24 2007-02-23 Immunomodulatory and anti-tumour peptides

Country Status (16)

Country Link
US (1) US8283324B2 (enExample)
EP (1) EP1992638B1 (enExample)
JP (1) JP5069250B2 (enExample)
KR (1) KR101456205B1 (enExample)
CN (1) CN101426813B (enExample)
AR (1) AR059608A1 (enExample)
AT (1) ATE493434T1 (enExample)
AU (1) AU2007218671B2 (enExample)
BR (1) BRPI0708148B1 (enExample)
CA (1) CA2638828C (enExample)
CU (1) CU23582A1 (enExample)
ES (1) ES2358845T3 (enExample)
MX (1) MX2008010893A (enExample)
RU (1) RU2430109C2 (enExample)
WO (1) WO2007095867A1 (enExample)
ZA (1) ZA200807034B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU23674A1 (es) * 2007-07-31 2011-05-27 Ct Ingenieria Genetica Biotech Péptidos penetradores a células fusionados a una biomolécula con acción terapéutica
EP2108372A1 (en) * 2008-04-09 2009-10-14 Forschungszentrum Borstel Leibniz-Zentrum für Medizin und Biowissenschaften Novel antimicrobial peptides
JP5964233B2 (ja) * 2009-09-11 2016-08-03 プロイェクト、デ、ビオメディシナ、シーマ、ソシエダッド、リミターダＰｒｏｙｅｃｔｏ Ｄｅ Ｂｉｏｍｅｄｉｃｉｎａ Ｃｉｍａ， Ｓ．Ｌ． Ｈｐｖにより惹起される疾患の治療用組成物
CU23897B1 (es) * 2010-05-31 2013-05-31 Ct De Ingeniería Genética Y Biotecnología Péptido para la terapia del cáncer
CN103724412A (zh) * 2013-09-29 2014-04-16 中国科学院海洋研究所 中国明对虾抗脂多糖因子及其制备和应用
US20250382330A1 (en) * 2022-06-29 2025-12-18 Cdres Pharma Llc Immunologically active polypeptide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08503490A (ja) * 1993-08-18 1996-04-16 モルフォシス・ゲゼルシャフト・フュア・プロタインオプティミールング・ミット・ベシュレンクテル・ハフツング リポ多糖結合性および中和能のあるペプチド
CU22700A1 (es) * 1997-09-29 2001-07-31 Ct Ingenieria Genetica Biotech Formulación farmacéutica anti-viral que contiene un péptido de la proteína factor anti-lps de limulus y su uso
AU2002214876A1 (en) 2000-11-08 2002-05-21 Lorus Therapeutics Inc. Combination preparation of a biological response modifier and an anticancer agent and uses thereof

Also Published As

Publication number Publication date
RU2430109C2 (ru) 2011-09-27
JP2009527510A (ja) 2009-07-30
EP1992638A1 (en) 2008-11-19
US8283324B2 (en) 2012-10-09
AU2007218671A1 (en) 2007-08-30
RU2008137968A (ru) 2010-03-27
BRPI0708148B1 (pt) 2019-01-15
KR20080106446A (ko) 2008-12-05
CA2638828A1 (en) 2007-08-30
WO2007095867A1 (es) 2007-08-30
AR059608A1 (es) 2008-04-16
KR101456205B1 (ko) 2014-10-31
MX2008010893A (es) 2008-09-03
JP5069250B2 (ja) 2012-11-07
BRPI0708148A2 (pt) 2011-05-17
EP1992638B1 (en) 2010-12-29
ZA200807034B (en) 2009-06-24
CN101426813A (zh) 2009-05-06
ES2358845T3 (es) 2011-05-16
US20090221508A1 (en) 2009-09-03
CN101426813B (zh) 2012-04-04
CA2638828C (en) 2014-09-09
CU23582A1 (es) 2010-10-30
ATE493434T1 (de) 2011-01-15

Similar Documents

Publication Publication Date Title
JP5294271B2 (ja) Ｃｄｈ３ペプチド及びこれを含む薬剤
AU2007218671B2 (en) Immunomodulatory and anti-tumour peptides
US10590179B2 (en) Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells
US20100167321A1 (en) Epitope/peptide recognized by hla-a2402-restricted ep-cam-specific ctl and use of the same
JP4780540B2 (ja) サバイビン由来癌抗原ペプチド
JP6481873B2 (ja) Ｍｕｃ１由来のペプチド、これを用いた癌の治療又は予防のための医薬組成物、免疫誘導剤、及び抗原提示細胞の製造方法
WO2007018198A1 (ja) Hla-a2陽性者用hsp105由来癌拒絶抗原ペプチド及びこれを含む医薬
WO2023163094A1 (ja) 成人ｔ細胞白血病の治療又は予防のための医薬組成物
TW202544022A (zh) 源自SARS-CoV-2蛋白之胜肽及含其之疫苗
HK1141832A (en) Cdh3 peptide and medicinal agent comprising the same

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired